<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To our knowledge, the use of transdermal <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> ointment (Nitropaste) in the setting of <z:e sem="disease" ids="C0751895" disease_type="Disease or Syndrome" abbrv="">intracranial vasospasm</z:e> has not been described in the peer-reviewed literature </plain></SENT>
<SENT sid="1" pm="."><plain>Five patients with <z:e sem="disease" ids="C0751895" disease_type="Disease or Syndrome" abbrv="">intracranial vasospasm</z:e> induced by <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> were evaluated angiographically both before and after application of Nitropaste </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cases exhibited mild to moderate improvement in the degree of vasospasm </plain></SENT>
<SENT sid="3" pm="."><plain>We conclude that Nitropaste is a simple noninvasive technique to reduce <z:e sem="disease" ids="C0751895" disease_type="Disease or Syndrome" abbrv="">intracranial vasospasm</z:e> </plain></SENT>
</text></document>